Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms

We analyzed 597 patients with myeloproliferative neoplasms (MPN) who presented transient ischemic attacks (TIA, n = 270) or ischemic stroke (IS, n = 327). Treatment included aspirin, oral anticoagulants, and cytoreductive drugs. The composite incidence of recurrent TIA and IS, acute myocardial infar...

Descripción completa

Detalles Bibliográficos
Autores principales: De Stefano, Valerio, Carobbio, Alessandra, Di Lazzaro, Vincenzo, Guglielmelli, Paola, Iurlo, Alessandra, Finazzi, Maria Chiara, Rumi, Elisa, Cervantes, Francisco, Elli, Elena Maria, Randi, Maria Luigia, Griesshammer, Martin, Palandri, Francesca, Bonifacio, Massimiliano, Hernandez-Boluda, Juan-Carlos, Cacciola, Rossella, Miroslava, Palova, Carli, Giuseppe, Beggiato, Eloise, Ellis, Martin H., Musolino, Caterina, Gaidano, Gianluca, Rapezzi, Davide, Tieghi, Alessia, Lunghi, Francesca, Loscocco, Giuseppe Gaetano, Cattaneo, Daniele, Cortelezzi, Agostino, Betti, Silvia, Rossi, Elena, Finazzi, Guido, Censori, Bruno, Cazzola, Mario, Bellini, Marta, Arellano-Rodrigo, Eduardo, Bertozzi, Irene, Sadjadian, Parvis, Vianelli, Nicola, Scaffidi, Luigi, Gomez, Montse, Cacciola, Emma, Vannucchi, Alessandro M., Barbui, Tiziano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849668/
https://www.ncbi.nlm.nih.gov/pubmed/29535299
http://dx.doi.org/10.1038/s41408-018-0048-9

Ejemplares similares

Ejemplares similares